返回
NervGen Pharma Corp.（NGENF）價格
NGENF 股價走勢圖
NGENF 股利
NervGen Pharma Corp.
$5.07
-2.87%
$-0.14
收盤價：Jan 26, 16:00:00 GMT-5
$5.07
0%
$0
盤後：Jan 26, 18:45:10 GMT-5
關鍵數據
前收市價
$5.22
開盤價
$5.17
當日範圍
$4.8 - $5.23
52週區間
$1.5 - $6.3
交易量
132.7K
平均成交量
143.3K
每股盈餘 (TTM)
-0.26
股息收益率
--
市值
$401.6M
什麼是 NervGen Pharma Corp.？
NervGen Pharma Corp. operates as a clinical stage biotech company. The company is headquartered in Vancouver, British Columbia. The company went IPO on 2019-03-13. The firm is engaged in developing treatments to promote nervous system repair in the settings of neurotrauma and neurologic disease. NVG-291 is in a Phase 1b/2a clinical trial in spinal cord injury and has undertaken preclinical evaluation of a new development candidate, NVG-300, in models of ischemic stroke, amyotrophic lateral sclerosis (ALS) and spinal cord injury (SCI). Its NVG-291 is a therapeutic peptide targeting nervous system repair.
